The direct antagonistic actions of gonadotropinreleasing hormone (GnRH) and its agonist analogs on hormonal (hCG and epinephrine) activation of progesterone and cAMP production in isolated luteal cells were described in the preceding paper. These effects are mediated by specific, high affinity GnRH receptors demonstrated in both ovarian membranes and isolated luteal cells. The present studies show that the administration of GnRH agonist analogs in vivo markedly inhibits PMS gonadotropin (PMSG)-induced follicular development and the increased formation of LH receptors after hCG-induced luteinization. Three GnRH agonist analogs with structural modifications at positions 6 and 10 given by osmotic minipump infusion, caused complete inhibition of the trophic actions of both gonadotropins. An antagonist analog which binds to the ovarian GnRH receptor with high affinity did not inhibit the gonadotropin-induced changes.Using the PMSG/hCG-primed immature rat, the effects of a single injection of GnRH were studied and compared to the action of hCG. Whereas the latter caused a marked loss of GnRH and LH receptors, GnRH caused a loss of ovarian LH receptors but a consistent increase in ovarian GnRH receptors; PRL receptors also showed a transient decline, and there was a fall in serum progesterone. In hypophysectomized rats, GnRH and hCG similarly caused a decrease in ovarian LH receptors and a transient change in the PRL receptor concentration. The GnRHinduced decrease in LH and PRL receptors in hypophysectomized animals indicates that GnRH analogs can act directly on the ovary and that their effects are not only due to the secondary release of gonadotropins from the pituitary gland. The direct inhibitory actions of this class of GnRH peptides upon gonadal function constitutes an important component of the antifertility effects of these compounds. (Endocrinology 107: 414, 1980). G ONADAL receptor sites for GnRH, 1 recently identified in the luteinized rat ovary (1) and characterized in the preceding paper (2), are responsible for mediating the direct inhibitory effects of GnRH agonists on ovarian function (3-6). Such direct ovarian effects of GnRH agonists, together with indirect actions exerted via gonadal desensitization by elevation of endogenous gonadotropins (7, 8) and pituitary refractoriness (9, 10), are responsible for the marked inhibitory effects of GnRH peptides upon reproductive function. The demonstration that GnRH agonists inhibit FSH-induced steroidogenesis in cultured granulosa cells (5) suggests that GnRH receptors are also present in ovarian follicles and are retained during subsequent luteinization. It was therefore of interest to determine whether the immature ovary contained GnRH receptors before gonadotropin priming and to correlate these sites with the ability of GnRH to antagonize the effects of exogenous PMS gonadotropin (PMSG) and hCG on ovarian development.